Menu

Myriad Genetics, Inc. MYGN

Full chart Compare
Set alert

Price alert · MYGN

All alert types
5.74 USD -0.18 (-3.04%)

At closeNov 9, 2026, 4:00 PM EST

5.74 0.00 0.00%

After hours · Nov 9, 4:00 PM ET

5.63 Day range 5.93
2.74 52-week range 8.09
YTD
-6.67%
1 year
-8.89%

Revenue & Expenses

Other Income → Expenses: $2.60MIncome Tax Benefit → Expenses: $29.20MExpenses → Selling, General & Admin: $537.60MExpenses → Research & Development: $106.80MExpenses → Other Operating Expenses: $319.40MExpenses → Interest Expense: $10.50MGross Profit → Expenses: $576.60MRevenue → Gross Profit: $576.60MRevenue → Cost of Revenue: $247.90MNet Loss → Expenses: $365.90MOther Income$2.60MIncome Tax Benefit$29.20MGross Profit$576.60MNet Loss$365.90MCost of Revenue$247.90MExpenses$974.30MSelling, General & Admin$537.60MResearch & Development$106.80MOther Operating Expenses$319.40MInterest Expense$10.50MRevenue$824.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

MYGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
824.50M837.60M753.20M678.40M690.60M
576.60M585.40M517.00M476.40M493.00M
-387.20M-123.50M-257.40M-140.60M-190.50M
-365.90M-127.30M-263.30M-112.00M-27.20M
-3.95-1.41-3.18-1.39-0.35
MYGN annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
149.60M102.40M132.10M56.90M257.40M
706.60M1.03B1.15B1.20B1.32B
338.60M326.50M363.30M312.90M352.90M
209.80M140.30M152.10M145.00M92.30M
368.00M701.10M783.20M885.80M967.80M
MYGN annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.80M-8.70M-110.90M-106.30M18.60M
-27.40M-11.90M31.90M-77.50M274.40M
64.20M-7.40M152.90M-8.00M-150.60M
-27.40M-29.70M-73.30M-45.30M-18.00M
39.40M-29.00M74.50M-192.40M141.80M